InteKrin Therapeutics Gets Investment
Palo Alto-based InteKrin Therapeutics, a stealth startup working on treatments for neuroendocrine and metabolic diseases, has received a round of funding, according to a regulatory filing. Investors in InteKrin include Sears Capital Management, which is headed by former Amgen CFO Lowell Sears.
posted on Tuesday, September 26, 2006 (Link to more information)
Related companies:
InteKrin Therapeutics
Related stories:
> InteKrin Scores $23M
> Bioabsorbable Therapeutics Scores Series B
> Global Blood Therapeutics Finds $48M
> Merck Buys Sirna Therapeutics
> Iconic Therapeutics Finds $20M
silicontap.com Home